NCT04026711View on ClinicalTrials.gov

MitoQ for the Treatment of Metabolic Dysfunction in Asthma

PHASE1CompletedINTERVENTIONAL

Enrollment

47

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

March 31, 2024

Study Completion Date

March 31, 2024

Conditions

AsthmaObesity

Interventions

DRUG

Mitoquinol

Mitoquinol (MitoQ) 40 mg per day for 12 weeks

DRUG

Placebo oral tablet

Placebo daily for 12 weeks

Trial Locations (2)

27710

Duke University, Durham

05405

University of Vermont, Burlington

Sponsors

Collaborators (1)

Duke University

All Listed Sponsors

collaborator

Duke University

OTHER

lead

University of Vermont

OTHER